GGrantIndex
Sort

21,281 grants matching influenza

Animal Medicine COVID Support

$3,453,487
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIG · FY2023 · AI

Therapeutic Monoclonal Antibodies to H5N1 Influenza

$3,435,365
Richard John Webby · St. Jude Children'S Research Hospital · U01 · FY2010 · AI

Omics-Based Predictive Modeling of Age-Dependent Outcome to Influenza Infection

$3,425,581
Elodie Ghedin · New York University · U01 · FY2016 · AI

Alaska INBRE-2: Environmental Agents and Disease

$3,403,303
Cheryl A Frye · University Of Alaska Fairbanks · P20 · FY2013 · GM

Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity

$3,381,331
Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2025 · AI

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,378,947
University Of California Los Angeles · P01 · FY2004 · HL

ADDRESSING EMERGING INFECTIOUS DISEASES IN BANGLADESH

$3,375,299
Sara Latrielle · International Ctr/Diarrhoeal Dis Res · U01 · FY2012 · CI

Adjuvant discovery for vaccines against West Nile Virus and Influenza

$3,360,262
Herman Staats · Duke University · N01 · FY2014 · AI

Treatment of Respiratory Viruses

$3,352,793
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA

The Viral and Respiratory Pathogens Research Center

$3,343,766
David Topham · University Of Rochester · N01 · FY2012 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$3,339,975
Richard Rothman · Johns Hopkins University · N01 · FY2016 · AI

Developing Inhibitors of Seasonal and Pandemic Influenza Viruses

$3,323,410
Richard K. Plemper · Georgia State University · R01 · FY2025 · AI

ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH

$3,318,845
Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2018 · GH

ARRA: H1N1 and Other ARRA Equipment

$3,314,695
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2010 · AI

Adjuvant development in the context of seasonal and pandemic influenza

$3,308,745
Jay Evans · University Of Montana · N01 · FY2019 · AI

Novel Innate Immune Adjuvant for Avian Influenza. West Nile Virus, and ZIKA Vaccines

$3,307,969
Michael Gale · University Of Washington · N01 · FY2017 · AI

Vaccine Induced Immunity in the Young and Aged

$3,300,759
Rafi Ahmed · Emory University · U19 · FY2010 · AI

Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory

$3,299,716
Erin June Adams · University Of Chicago · G20 · FY2021 · AI

Task X3: Evaluation of Clinical Samples from Influenza Clinical Trials

$3,299,568
Norman Kneteman · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2013 · AI

Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory

$3,293,351
Erin June Adams · University Of Chicago · G20 · FY2022 · AI

NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR)

$3,283,220
Scott Hensley · University Of Pennsylvania · N01 · FY2023 · AI

Vaccination and infection: indicators of immunological health and responsiveness

$3,271,801
Mark M Davis · Stanford University · U19 · FY2011 · AI

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,270,696
University Of California Los Angeles · P01 · FY2003 · HL

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site

$3,268,655
Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2023 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES

$3,250,144
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2022 · AI